학술논문

REDUCTION IN THE CEREBROSPINAL FLUID PROTEIN LEVEL AFTER BEVACIZUMAB TREATMENT IN PATIENTS WITH OPTIC PATHWAY LOW-GRADE GLIOMAS
Document Type
Journal
Source
NEURO-ONCOLOGY; JUN 2022, 24 p98-p98, 1p. Supplement: 1
Subject
Language
English
ISSN
15235866